By Ransdell Pierson
NEW YORK (Reuters) - Johnson & Johnson (JNJ.N) plans to cut up to 7 percent of its workforce in order to generate cost savings needed to finance increasingly costly drug research and to weather future challenges, the diversified healthcare company said on Tuesday.
